정형외과용 임플란트 시장 : 시장 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰 및 예측(2026-2034년)

Growth Factors of orthopedic implants Market

The global orthopedic implants market is witnessing significant growth due to the rising prevalence of orthopedic disorders, increasing geriatric population, and technological innovations in implant procedures. Orthopedic implants are medical devices used to replace or support bones and joints, aiming to reduce pain, restore mobility, and improve functionality. Common applications include joint reconstruction, spinal implants, trauma implants, and others, catering to patients with fractures, arthritis, bone deformities, or sports injuries.

As per Fortune Business Insights, the global orthopedic implants market was valued at USD 49.73 billion in 2025, projected to reach USD 52.24 billion in 2026, and expand to USD 80.44 billion by 2034, reflecting a CAGR of 5.54% during the forecast period. North America dominated the market in 2025 with a 55.28% share, driven by advanced healthcare infrastructure, high patient awareness, and favorable reimbursement policies. Leading players include Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Smith & Nephew, and Stryker, focusing on innovative product development to strengthen their global presence.

Market Drivers

Rising Geriatric Population and Orthopedic Disorders: The global increase in geriatric population is fuelling demand for orthopedic surgeries. According to WHO, the proportion of people aged 60 and above is projected to reach 22% by 2050, nearly doubling from 12% in 2015. Geriatric patients are more prone to fractures, arthritis, and spinal conditions, leading to higher adoption of implants. Globally, 8.9 million fractures occur annually, highlighting the need for effective orthopedic treatments. Favorable reimbursement policies, such as Medicare covering 10.5% of orthopedic procedure costs, further encourage implant usage.

Technological Innovation and Investment: Market players are heavily investing in research and development for novel implants, including personalized and 3D-printed solutions. For example, in January 2023, Trabtech announced USD 1.4 million in funding for new orthopedic and pediatric implant development. Such innovations improve surgical outcomes, patient satisfaction, and product adoption rates.

Market Restraints

High Cost and Surgical Risks: Orthopedic implants are associated with high procedure costs, ranging from USD 15,000 to USD 70,000 for knee replacement surgeries. Additionally, potential side effects like implant rejection, septic arthritis, osteomyelitis, and device failure limit adoption among certain patient groups. These factors, combined with revision surgeries, may reduce market growth.

Regulatory and Manufacturing Challenges: Stringent regulations and lengthy clinical trials delay the launch of new products. Advanced implants, such as those made from bioactive ceramics or specialized polymers, require complex manufacturing processes, acting as additional market constraints.

Market Opportunities

Expansion in Emerging Markets: Market players are focusing on middle- and low-income countries where improving healthcare infrastructure presents opportunities for orthopedic implant adoption.

Adoption of Advanced Technology: The integration of AI, robotic-assisted surgery, 3D printing, and smart navigation systems is revolutionizing implant procedures. For instance, in March 2023, Curiteva, Inc. received FDA approval for a 3D-printed cervical interbody system, demonstrating the trend of personalized implants.

Market Trends

• Increasing adoption of robot-assisted orthopedic surgeries and AI-powered guidance software.
• Growing utilization of 3D printing for customized, multi-layered implants.
• Rising government support and investments in orthopedic device innovation.

Segmentation Analysis

By Product:

• Joint Reconstruction: Dominant segment with 46.44% share in 2026, driven by knee and hip replacements.
• Spinal Implants: Growing demand due to spinal disorders like scoliosis and spondylitis.
• Trauma Implants & Others: Fastest CAGR, fueled by sports injuries and road accidents.

By Material:

• Metal Alloys: Largest segment (31.05% in 2026) used primarily in joint reconstruction.
• Polymers: Fastest-growing, driven by adoption of PEEK polymer implants.
• Ceramics and Hybrids: Niche applications in specialized surgeries.

By Procedure:

• Knee Arthroplasty: Leading segment (30.69% in 2026), growing due to rising knee surgeries globally.
• Hip Arthroplasty and Spinal Procedures: Steady growth from aging population and musculoskeletal disorders.

By End-User:

• Hospitals & Ambulatory Surgery Centers: Dominant segment (56.25% in 2026) due to reimbursement coverage and advanced implantation facilities.
• Orthopedic Clinics & Others: Fastest CAGR driven by private practices and remote surgery capabilities.

Regional Outlook

North America: Dominates with USD 27.49 billion in 2025, projected to reach USD 26.28 billion in 2026. High incidence of fractures, advanced healthcare infrastructure, and strategic collaborations drive growth.

Europe: Second-largest market; UK USD 1.14 billion, Germany USD 2.97 billion in 2026. Growth driven by arthritis prevalence, reimbursement policies, and minimally invasive implant adoption.

Asia Pacific: Fastest-growing, Japan USD 2.99 billion, China USD 2.57 billion, India USD 0.58 billion in 2026, fueled by improved diagnostics, healthcare infrastructure, and supportive government regulations.

Latin America & Middle East/Africa: Moderate growth due to expanding healthcare infrastructure and increasing joint replacement procedures.

Competitive Landscape

Key market leaders such as Zimmer Biomet, DePuy Synthes, Smith+Nephew, and Stryker dominate through R&D investments, innovative product launches, and strategic partnerships. Recent developments include:

• October 2024: Smith+Nephew launched LEGION Hinged Knee System in the U.S.
• September 2023: Enovis acquired LimaCorporate S.p.A., expanding global implant portfolio.
• May 2023: Zimmer Biomet introduced Persona Osseo Ti KEEL Tibia, a cement-less knee implant for personalized procedures.

Conclusion

The global orthopedic implants market is poised to grow from USD 49.73 billion in 2025 to USD 52.24 billion in 2026, reaching USD 80.44 billion by 2034 at a CAGR of 5.54%. Growth is driven by aging populations, rising orthopedic disorders, and technological innovations such as AI, robotics, and 3D printing. North America leads the market, followed by Europe and Asia Pacific, while increasing investments, personalized implants, and adoption in emerging markets are expected to drive long-term growth.

Segmentation By Product

• Joint Reconstruction
  • Knee
  • Hip
  • Extremities
• Spinal Implants
  • Spinal Fusion Devices
  • Spinal Non-Fusion Devices
• Trauma Implants
• Others

By Material

• Metal Alloys
• Polymers
• Ceramics
• Hybrid

By Procedure

• Hip Arthroplasty
• Knee Arthroplasty
• Spinal Procedure
• Others

By End-user

• Hospitals & Ambulatory Surgery Centers
• Orthopedic Clinics & Others

By Geography

• North America (By Product, By Material, By Procedure, By End-user, and By Country/ Sub-region)
  • U.S. (By Product)
  • Canada (By Product)
• Europe (By Product, By Material, By Procedure, By End-user, and By Country/ Sub-region)
  • Germany (By Product)
  • U.K. (By Product)
  • France (By Product)
  • Italy (By Product)
  • Spain (By Product)
  • Scandinavia (By Product)
  • Rest of Europe (By Product)
• Asia Pacific (By Product, By Material, By Procedure, By End-user, and By Country/Sub-region)
  • China (By Product)
  • India (By Product)
  • Japan (By Product)
  • Australia (By Product)
  • South East Asia (By Product)
  • Rest of Asia Pacific (By Product)
• Latin America (By Product, By Material, By Procedure, By End-user, and By Country/Sub-region)
  • Brazil (By Product)
  • Mexico (By Product)
  • Rest of Latin America (By Product)
• Middle East & Africa (By Product, By Material, By Procedure, By End-user, and By Country/Sub-region)
  • GCC (By Product)
  • South Africa (By Product)
  • Rest of Middle East & Africa (By Product)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Statistics: Key Orthopedic Procedures Performed in Key Countries, 2025
• 4.2. New Product Launches, By Key Players
• 4.3. Key Industry Developments: Mergers, Acquisitions, Etc.

5. Global Orthopedic Implants Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Joint Reconstruction
    • 5.1.1.1. Knee
    • 5.1.1.2. Hip
    • 5.1.1.3. Extremities
  • 5.1.2. Spinal Implants
    • 5.1.2.1. Spinal Fusion Devices
    • 5.1.2.2. Spinal Non-Fusion Devices
  • 5.1.3. Trauma Implants
  • 5.1.4. Others
• 5.2. Market Analysis, Insights and Forecast - By Material
  • 5.2.1. Metal Alloys
  • 5.2.2. Polymers
  • 5.2.3. Ceramics
  • 5.2.4. Hybrid
• 5.3. Market Analysis, Insights and Forecast - By Procedure
  • 5.3.1. Hip Arthroplasty
  • 5.3.2. Knee Arthroplasty
  • 5.3.3. Spinal Procedure
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals & Ambulatory Surgery Centers
  • 5.4.2. Orthopedic Clinics & Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Orthopedic Implants Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Joint Reconstruction
    • 6.1.1.1. Knee
    • 6.1.1.2. Hip
    • 6.1.1.3. Extremities
  • 6.1.2. Spinal Implants
    • 6.1.2.1. Spinal Fusion Devices
    • 6.1.2.2. Spinal Non-Fusion Devices
  • 6.1.3. Trauma Implants
  • 6.1.4. Others
• 6.2. Market Analysis, Insights and Forecast - By Material
  • 6.2.1. Metal Alloys
  • 6.2.2. Polymers
  • 6.2.3. Ceramics
  • 6.2.4. Hybrid
• 6.3. Market Analysis, Insights and Forecast - By Procedure
  • 6.3.1. Hip Arthroplasty
  • 6.3.2. Knee Arthroplasty
  • 6.3.3. Spinal Procedure
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals & Ambulatory Surgery Centers
  • 6.4.2. Orthopedic Clinics & Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Product
  • 6.5.2. Canada
    • 6.5.2.1. By Product

7. Europe Orthopedic Implants Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Joint Reconstruction
    • 7.1.1.1. Knee
    • 7.1.1.2. Hip
    • 7.1.1.3. Extremities
  • 7.1.2. Spinal Implants
    • 7.1.2.1. Spinal Fusion Devices
    • 7.1.2.2. Spinal Non-Fusion Devices
  • 7.1.3. Trauma Implants
  • 7.1.4. Others
• 7.2. Market Analysis, Insights and Forecast - By Material
  • 7.2.1. Metal Alloys
  • 7.2.2. Polymers
  • 7.2.3. Ceramics
  • 7.2.4. Hybrid
• 7.3. Market Analysis, Insights and Forecast - By Procedure
  • 7.3.1. Hip Arthroplasty
  • 7.3.2. Knee Arthroplasty
  • 7.3.3. Spinal Procedure
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals & Ambulatory Surgery Centers
  • 7.4.2. Orthopedic Clinics & Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.5.1. Germany
    • 7.5.1.1. By Product
  • 7.5.2. U.K.
    • 7.5.2.1. By Product
  • 7.5.3. France
    • 7.5.3.1. By Product
  • 7.5.4. Italy
    • 7.5.4.1. By Product
  • 7.5.5. Spain
    • 7.5.5.1. By Product
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Product
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Product

8. Asia Pacific Orthopedic Implants Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Joint Reconstruction
    • 8.1.1.1. Knee
    • 8.1.1.2. Hip
    • 8.1.1.3. Extremities
  • 8.1.2. Spinal Implants
    • 8.1.2.1. Spinal Fusion Devices
    • 8.1.2.2. Spinal Non-Fusion Devices
  • 8.1.3. Trauma Implants
  • 8.1.4. Others
• 8.2. Market Analysis, Insights and Forecast - By Material
  • 8.2.1. Metal Alloys
  • 8.2.2. Polymers
  • 8.2.3. Ceramics
  • 8.2.4. Hybrid
• 8.3. Market Analysis, Insights and Forecast - By Procedure
  • 8.3.1. Hip Arthroplasty
  • 8.3.2. Knee Arthroplasty
  • 8.3.3. Spinal Procedure
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals & Ambulatory Surgery Centers
  • 8.4.2. Orthopedic Clinics & Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.5.1. China
    • 8.5.1.1. By Product
  • 8.5.2. India
    • 8.5.2.1. By Product
  • 8.5.3. Japan
    • 8.5.3.1. By Product
  • 8.5.4. Australia
    • 8.5.4.1. By Product
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Product
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Product

9. Latin America Orthopedic Implants Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Joint Reconstruction
    • 9.1.1.1. Knee
    • 9.1.1.2. Hip
    • 9.1.1.3. Extremities
  • 9.1.2. Spinal Implants
    • 9.1.2.1. Spinal Fusion Devices
    • 9.1.2.2. Spinal Non-Fusion Devices
  • 9.1.3. Trauma Implants
  • 9.1.4. Others
• 9.2. Market Analysis, Insights and Forecast - By Material
  • 9.2.1. Metal Alloys
  • 9.2.2. Polymers
  • 9.2.3. Ceramics
  • 9.2.4. Hybrid
• 9.3. Market Analysis, Insights and Forecast - By Procedure
  • 9.3.1. Hip Arthroplasty
  • 9.3.2. Knee Arthroplasty
  • 9.3.3. Spinal Procedure
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals & Ambulatory Surgery Centers
  • 9.4.2. Orthopedic Clinics & Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Product
  • 9.5.2. Mexico
    • 9.5.2.1. By Product
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Product

10. Middle East & Africa Orthopedic Implants Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product
  • 10.1.1. Joint Reconstruction
    • 10.1.1.1. Knee
    • 10.1.1.2. Hip
    • 10.1.1.3. Extremities
  • 10.1.2. Spinal Implants
    • 10.1.2.1. Spinal Fusion Devices
    • 10.1.2.2. Spinal Non-Fusion Devices
  • 10.1.3. Trauma Implants
  • 10.1.4. Others
• 10.2. Market Analysis, Insights and Forecast - By Material
  • 10.2.1. Metal Alloys
  • 10.2.2. Polymers
  • 10.2.3. Ceramics
  • 10.2.4. Hybrid
• 10.3. Market Analysis, Insights and Forecast - By Procedure
  • 10.3.1. Hip Arthroplasty
  • 10.3.2. Knee Arthroplasty
  • 10.3.3. Spinal Procedure
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals & Ambulatory Surgery Centers
  • 10.4.2. Orthopedic Clinics & Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.5.1. GCC Countries
    • 10.5.1.1. By Product
  • 10.5.2. South Africa
    • 10.5.2.1. By Product
  • 10.5.3. Rest of Middle East & Africa
    • 10.5.3.1. By Product

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Zimmer Biomet
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Johnson & Johnson Services, Inc.
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Smith+Nephew
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Stryker
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Agilent Technologies, Inc.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. CONMED Corporation
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Medtronic
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. DJO LLC.
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Exactech, Inc.
    • 11.2.9.1. Overview
    • 11.2.9.2. Products
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Corin Group
    • 11.2.10.1. Overview
    • 11.2.10.2. Products
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)
  • 11.2.11. Conformis
    • 11.2.11.1. Overview
    • 11.2.11.2. Products
    • 11.2.11.3. SWOT Analysis
    • 11.2.11.4. Recent Developments
    • 11.2.11.5. Strategies
    • 11.2.11.6. Financials (Based on Availability)
  • 11.2.12. United Orthopedic Corporation
    • 11.2.12.1. Overview
    • 11.2.12.2. Products
    • 11.2.12.3. SWOT Analysis
    • 11.2.12.4. Recent Developments
    • 11.2.12.5. Strategies
    • 11.2.12.6. Financials (Based on Availability)
  • 11.2.13. Medacta International
    • 11.2.13.1. Overview
    • 11.2.13.2. Products
    • 11.2.13.3. SWOT Analysis
    • 11.2.13.4. Recent Developments
    • 11.2.13.5. Strategies
    • 11.2.13.6. Financials (Based on Availability)
  • 11.2.14. Globus Medical
    • 11.2.14.1. Overview
    • 11.2.14.2. Products
    • 11.2.14.3. SWOT Analysis
    • 11.2.14.4. Recent Developments
    • 11.2.14.5. Strategies
    • 11.2.14.6. Financials (Based on Availability)
  • 11.2.15. B. Braun SE
    • 11.2.15.1. Overview
    • 11.2.15.2. Products
    • 11.2.15.3. SWOT Analysis
    • 11.2.15.4. Recent Developments
    • 11.2.15.5. Strategies
    • 11.2.15.6. Financials (Based on Availability)